Background: Prostate cancer is a common cause of morbidity and mortality among men aged 40 years and older. Evidence has shown that awareness of prostate cancer plays a greater role in the early detection of prostate cancer. However, there is a paucity of information regarding prostate cancer awareness levels in Ethiopia in general and in Mizan Aman town in particular.
Objectives: To assess the awareness of prostate cancer and its associated factors among men aged 40 years and older in Mizan Aman, Bench Sheko zone, Southern Nations, Nationalities, and Peoples' Region, South West Ethiopia, 2019.
Methods: A community-based cross-sectional study was conducted from 1 to 30 April 2021 in Mizan Aman town. A total of 322 study subjects were selected from a total population of 1,242 in Mizan Aman town by using the simple random sampling method. Data were collected through a face-to-face interview using a structured questionnaire. Data were entered into EpiData version 3.1 and analyzed by Statistical Package for Social Science version 20. Descriptive statistics were used to summarize sociodemographic characteristics and personal history. Bivariate and multivariate regression analyses were used to explore further variables that were associated with the level of awareness. Significant associations were declared at a -value of <0.05. The results were presented in text, tables, and charts.
Results: The magnitude of prostate cancer awareness was 64%. Participants who were between 40 and 55 years of age (adjusted odd ratio = 6.16, 95% confidence interval = 2.62-14.47), who were government employees (adjusted odd ratio = 4.684, 95% confidence interval = 1.56-13.97), and whose monthly income level is greater than 5,000 birr (adjusted odd ratio = 12.45, 95% confidence interval = 3.2-47.77) were significantly associated with the level of awareness.
Conclusion And Recommendation: This study revealed that more than half of the men residing in Mizan Aman town had a high level of prostate cancer awareness. First-category age, better economic status, and employment were significantly associated with awareness of prostate cancer. This indicates the need for a collective effort to enhance the awareness of men regarding prostate cancer.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638119 | PMC |
http://dx.doi.org/10.3389/fonc.2022.976810 | DOI Listing |
Int Urol Nephrol
January 2025
Department of Urology and Urosurgery, Medical Faculty Mannheim, University Medical Centre Mannheim (UMM), University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Baden-Württemberg, Germany.
Purpose: To identify prognostic factors for overall survival (OS) and develop a prognostic score in patients receiving docetaxel in metastatic castration-resistant prostate cancer (mCRPC).
Methods: Retrospective analysis was conducted on mCRPC patients treated with docetaxel at a German tertiary center between March 2010 and November 2023. Prognostic clinical and laboratory factors were analyzed using uni- and multivariable logistic regression.
Eur J Nucl Med Mol Imaging
January 2025
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Purpose: The study explores the role of multimodal imaging techniques, such as [F]F-PSMA-1007 PET/CT and multiparametric MRI (mpMRI), in predicting the ISUP (International Society of Urological Pathology) grading of prostate cancer. The goal is to enhance diagnostic accuracy and improve clinical decision-making by integrating these advanced imaging modalities with clinical variables. In particular, the study investigates the application of few-shot learning to address the challenge of limited data in prostate cancer imaging, which is often a common issue in medical research.
View Article and Find Full Text PDFJ Gen Intern Med
January 2025
Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Background: Active surveillance (AS) is the guideline-recommended treatment for low-risk prostate cancer and involves routine provider visits, lab tests, imaging, and prostate biopsies. Despite good uptake, adherence to AS, in terms of receiving recommended follow-up testing and remaining on AS in the absence of evidence of cancer progression, remains challenging.
Objective: We sought to better understand urologist, primary care providers (PCPs), and patient experiences with AS care delivery to identify opportunities to improve adherence.
Prostate Cancer Prostatic Dis
January 2025
Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin, 300211, China.
Objectives: To develop and validate a lesion-based grading system using clinicopathological and MRI features for predicting positive surgical margin (PSM) following robotic-assisted laparoscopic prostatectomy (RALP) among prostate cancer (PCa) patients.
Methods: Consecutive MRI examinations of patients undergoing RALP for PCa were retrospectively collected from two medical institutions. Patients from center 1 undergoing RALP between January 2020 and December 2021 were included in the derivation cohort and those between January 2022 and December 2022 were allocated to the validation cohort.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!